Patient stratification to deliver personalized medicine may be of great help in understanding and managing pulmonary diseases, such as idiopathic pulmonary fibrosis (IPF), according to researchers.
Stratification categorizes patients into subgroups according to disease progression, individual biomarkers, and distinct responses to therapy or predicted response to new treatments.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management